Related references
Note: Only part of the references are listed.Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort
Yuan Lu et al.
JAMA NETWORK OPEN (2022)
Effect of Intensive Glycemic and Blood Pressure Control on QT Prolongation in Diabetes: The ACCORD Trial
Matthew J. Singleton et al.
DIABETES (2020)
Cardiovascular risk factors in China: a nationwide population-based cohort study
Xi Li et al.
Lancet Public Health (2020)
Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous Cohorts
Seng Chan You et al.
KOREAN CIRCULATION JOURNAL (2020)
Geographical variations in cardiovascular health in China: A nationwide population-based survey of 74,726 adults
Mei Zhang et al.
LANCET REGIONAL HEALTH-WESTERN PACIFIC (2020)
Early cardiovascular protection by initial two-drug fixed-dose combination treatment vs. monotherapy in hypertension
Federico Rea et al.
EUROPEAN HEART JOURNAL (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Spatial and temporal characteristics of temperature effects on cardiovascular disease in Southern China using the Empirical Mode Decomposition method
Jixia Huang et al.
SCIENTIFIC REPORTS (2018)
Comparison of bisoprolol to a metoprolol CR/ZOK tablet for control of heart rate and blood pressure in mild-to-moderate hypertensive patients: the CREATIVE study
Tianlun Yang et al.
HYPERTENSION RESEARCH (2017)
Effects of calcium channel blocker benidipine-based combination therapy on target blood pressure control and cardiovascular outcome: a sub-analysis of the COPE trial
Seiji Umemoto et al.
HYPERTENSION RESEARCH (2017)
Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-Blockers
Tetsuro Tsujimoto et al.
HYPERTENSION (2017)
Relationship between initial therapy and blood pressure control for high-risk hypertension patients in the UK: a retrospective cohort study from the THIN general practice database
Sharada Weir et al.
BMJ OPEN (2017)
Management of Hypertension With a Fixed-Dose (Single-Pill) Combination of Bisoprolol and Amlodipine
Ulrike Gottwald-Hostalek et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2017)
Bisoprolol/amlodipine combination therapy improves blood pressure control in patients with essential hypertension following monotherapy failure
Ulrike Gottwald-Hostalek et al.
CURRENT MEDICAL RESEARCH AND OPINION (2016)
Combined effects of hypertension and heart rate on the risk of stroke and coronary heart disease: a population-based prospective cohort study among Inner Mongolians in China
Chongke Zhong et al.
HYPERTENSION RESEARCH (2015)
Combination Therapy in Hypertension
Manuel Gorostidi et al.
ADVANCES IN THERAPY (2013)
Effects of a benidipine-based combination therapy on the risk of stroke according to stroke subtype: the COPE trial
Seiji Umemoto et al.
HYPERTENSION RESEARCH (2013)
Combination therapy for hypertension in the elderly: a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial
Toshio Ogihara et al.
HYPERTENSION RESEARCH (2012)
Retrospective Analysis of Real-World Efficacy of Angiotensin Receptor Blockers Versus Other Classes of Antihypertensive Agents in Blood Pressure Management
Robert Petrella et al.
CLINICAL THERAPEUTICS (2011)
Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial
Masunori Matsuzaki et al.
JOURNAL OF HYPERTENSION (2011)
Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger people: meta-analysis of randomised trials
F. Turnbull et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
B Dahlöf et al.
LANCET (2002)
Cardiovascular adverse drug reaction associated with combined β-adrenergic and calcium entry-blocking agents
Y Edoute et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2000)
Share Paper
